Accelerate Diagnostics News
News
0
Ticker
AXDX
ISIN
US00430H2013
Accelerate Diagnostics Eulerpool News
Accelerate Diagnostics Stock News
Accelerate Diagnostics is being monitored by journalists and investors worldwide. We gather the latest Accelerate Diagnostics news here.
- May 14·Benzinga
- May 14·Benzinga
- May 13·Benzinga
- May 13·Benzinga
- May 8·Benzinga
- January 10·Yahoo
- November 9·SeekingAlpha
- November 8·Yahoo
- November 8·Yahoo
- November 7·Yahoo
- November 7·Yahoo
- November 7·Yahoo
- October 25·Yahoo
- October 9·Yahoo
- October 1·Yahoo
- October 1·Yahoo
- September 30·Yahoo
- September 30·PR Newswire
- September 30·Thefly.com
- August 19·Associated Press, The
Accelerate Diagnostics Stock Press Releases
Accelerate Diagnostics regularly publishes news on the company's website that are relevant for investors.
- November 14•Accelerate Diagnostics
- October 24•Accelerate Diagnostics
- August 18•Accelerate Diagnostics
- August 17•Accelerate Diagnostics
- August 15•Accelerate Diagnostics
- August 15•Accelerate Diagnostics
- July 25•Accelerate Diagnostics
- July 11•Accelerate Diagnostics
- May 23•Accelerate Diagnostics
- May 16•Accelerate Diagnostics
- May 16•Accelerate Diagnostics
- April 29•Accelerate Diagnostics
- April 25•Accelerate Diagnostics
- March 28•Accelerate Diagnostics
- March 8•Accelerate Diagnostics
- February 24•Accelerate Diagnostics
- February 2•Accelerate Diagnostics
- January 13•Accelerate Diagnostics
- January 12•Accelerate Diagnostics
- December 29•Accelerate Diagnostics
- November 22•Accelerate Diagnostics
- November 9•Accelerate Diagnostics
- October 19•Accelerate Diagnostics
- September 23•Accelerate Diagnostics
- August 5•Accelerate Diagnostics
- August 3•Accelerate Diagnostics
- July 15•Accelerate Diagnostics
- July 7•Accelerate Diagnostics
- June 30•Accelerate Diagnostics
- May 19•Accelerate Diagnostics
Accelerate Diagnostics News 2026
This page contains all current news, analysis and press releases for Accelerate Diagnostics stock (AXDX, ISIN: US00430H2013). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Accelerate Diagnostics.
Accelerate Diagnostics Stock
Accelerate Diagnostics Accelerate Diagnostics, Inc. generates revenue through its Accelerate Pheno system, an in vitro diagnostic platform that combines genotypic pathogen identification with phenotypic antibiotic susceptibility testing. The company sells the Accelerate Pheno system, including the fixed instrument and single-use test kits, to healthcare facilities for rapid diagnosis of serious infections. The Accelerate PhenoTest BC Kit specifically targets bacteremia and fungemia cases, providing ID and AST results directly from patient samples. Healthcare providers, particularly those treating life-threatening infections with high mortality risks, purchase these solutions to improve patient outcomes and reduce healthcare costs. The Accelerate Pheno system's walk-away automation feature reduces manual labor in laboratories, appealing to hospitals and clinical labs seeking efficiency. The company's focus on rapid diagnosis of serious infections aligns with healthcare institutions' needs for faster treatment decisions. By offering direct pathogen identification followed by targeted antibiotic testing, the system helps clinicians choose effective treatments more quickly, addressing high morbidity and mortality risks associated with bloodstream infections.